Posts Tagged ‘nasdaq bell ringing’
Sichenzia Ross Ference LLP Joins Cyngn Inc. in Ringing Opening Bell at Nasdaq MarketSite
New York, NY – May 11, 2022 – Sichenzia Ross Ference LLP partners Gregory Sichenzia and Marcelle Balcombe joined Cyngn Inc. (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial applications, for today’s opening bell ceremony at Nasdaq MarketSite in Times Square. Mr. Sichenzia represented Cyngn Inc. in their recent…
Read MoreSichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock
Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing
Press Release – New York, NY – October 15, 2019 – Sichenzia Ross Ference LLP founding partner Gregory Sichenzia will join representatives of client Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical stage, specialty pharmaceutical company, focused on treatment solutions for depression, CNS and ophthalmological disorders, at the Nasdaq MarketSite in Times Square to ring the October…
Read MorePartner Benjamin Tan Joins China Internet Nationwide Financial Services, Inc. in Ringing the Closing Bell at Nasdaq MarketSite
Press Release – New York, NY – August 16, 2017 – Sichenzia Ross Ference Kesner LLP partner, Benjamin Tan joined China Internet Nationwide Financial Services, Inc. (NASDAQ: CIFS) , a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in ringing the closing bell at Nasdaq MarketSite in Times Square on…
Read MoreSichenzia Ross Friedman Ference LLP Attorneys To Join Client DelMar Pharmaceuticals, Inc. at Nasdaq Opening Bell Ringing
Press Release – New York, NY – July 14, 2016 – Sichenzia Ross Friedman Ference LLP partners Gregory Sichenzia and David Manno and counsel Jeffrey Cahlon will join representatives of client DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a clinical stage drug development company with a focus on the treatment of cancer, at the Nasdaq MarketSite in Times…
Read More
